Andrzej Siemiatkowski

Andrzej Siemiatkowski

Auto-generated profile, based on publicly available information

Andrzej Siemiatkowski

Department of Anaesthesiology and Intensive Care, Medical University of Bialystok, Poland

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Pancreas
Verified
Journal Article
Closed access
UWUrszula Wereszczynska-Siemiatkowska
Urszula Wereszczynska-Siemiatkowska
AŚAgnieszka Świdnicka-Siergiejko
Agnieszka Świdnicka-Siergiejko
ASAndrzej Siemiatkowski
Andrzej Siemiatkowski
ADAndrzej Dąbrowski
Andrzej Dąbrowski
Objectives The exact time of initiation of total enteral nutrition (TEN) in severe acute pancreatitis (SAP) and its influence on the disease outcome are not well known. Methods An analysis of 197 cases with predicted SAP allocated to: group A (n = 97), early TEN (started within the first 48 hours after admission to hospital); and group B (n = 100), delayed TEN (started after 48 hours). Results Infection of necrosis/fluid collections occurred in 4 patients in group A and 18 patients in group B (P < 0.05). Respiratory failure and transfer to intensive care unit occurred more frequently in group B than in group A (15 vs 5 and 15 vs 3 patients; P < 0.05). Multiple-organ failure was observed in 9 patients in group A and 16 patients in group B (P > 0.05). Seven patients in group A and 11 patients in group B underwent surgery (P > 0.05). All 9 reported deaths occurred in group B (P < 0.05). The time to start TEN was a predictor of infected necrosis/fluid collection (odds ratio, 4.09; P = 0.028). Conclusions Delayed compared to early TEN is associated with higher mortality, increased frequency of infected necrosis/fluid collections, respiratory failure, and a need for intensive care unit hospitalization. Enteral nutrition in SAP should be started within 48 hours after admission to hospital.

27 December 2017 in Archivum Immunologiae et Therapiae Experimentalis
Verified
Journal Article
Open access
PDF file
MJMonika Jedynak
Monika Jedynak
ASAndrzej Siemiatkowski
Andrzej Siemiatkowski
Barbara MroczkoBarbara Mroczko
Barbara Mroczko
MGMagdalena Groblewska
Magdalena Groblewska
Robert MilewskiRobert Milewski
Robert Milewski
MSMaciej Szmitkowski
Maciej Szmitkowski
Early prognostic prediction of sepsis is essential in adjusting therapeutic protocols to prevent deterioration and reduce mortality. We compared the predictive value of the serum concentration of the soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) for 28-day mortality and for the development of severe sepsis or septic shock on the third day with the levels of interleukin (IL)-6, C-reactive protein (CRP) and procalcitonin (PCT). The study was conducted on 85 patients with sepsis. sTREM-1, CRP, PCT and IL-6 concentrations were measured upon study inclusion (day 0) and on days 1, 2, 3 and 5. APACHE II, SAPS II and SOFA scores were analyzed. The sTREM-1 levels (pg/ml) were higher in non-survivors than in survivors at admission (773 vs. 391, p < 0.001) and on days 1, 2, 3 and 5. In predicting the development of severe sepsis, the highest AUCs were found for PCT (0.744, 95% CI 0.638–0.85) and sTREM-1 (0.664, 95% CI 0.55–0.778); and in septic shock prediction, for PCT (0.766, 95% CI 0.665–0.867) and IL-6 (0.707, 95% CI 0.595–0.819). sTREM-1 positively correlated with APACHE II, SAPS II and SOFA scores. At inclusion, significant AUC for predicting 28-day mortality was 0.772 for the sTREM-1 (95% CI 0.672–0.871), 0.858 for APACHE II (95% CI 0.768–0.948), 0.847 for SAPS II (95% CI 0.733–0.96), 0.806 for SOFA score (95% CI 0.698–0.915). sTREM-1 can early predict the 28-day sepsis mortality, although its effectiveness is lower in comparison with clinical severity scores.

1 January 2002 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
UWU. Wereszczynska-Siemiatkowska
U. Wereszczynska-Siemiatkowska
Barbara MroczkoBarbara Mroczko
Barbara Mroczko
ASA. Siemiatkowski
A. Siemiatkowski
Background: Interleukin 18 (IL-18) is a new mediator and modulator of the immune response; its role in acute pancreatitis (AP), however, has not yet been fully explained. The aim of our study was to evaluate the profile IL-18 serum concentrations in the course of acute pancreatitis. Methods: The prospective study involves 30 patients with AP ( n = 15 with mild AP and n = 15 with severe AP) as well as 10 healthy subjects. AP severity was defined according to Ranson's and Balthazar's criteria, supplemented by serum CRP concentration measurements. In the course of hospitalization, 2 patients with severe AP died. Serum IL-18 and plasma polymorphonuclear leukocyte elastase (PMN-E) concentrations were measured at admission (day 1) and on days 2, 3, 5 and 10. Results: In both the mild and the severe forms of AP, serum IL-18 concentration was significantly higher than in the healthy controls. In severe AP, serum IL-18 reached the highest levels in all observed periods compared to that in patients with mild AP. Significant correlations, calculated for day 1, were found between serum IL-18 and plasma PMN-E (Rs = 0.514, P < 0.001) and between IL-18 and CRP (Rs = 0.463, P < 0.001) levels. Conclusions: Serum profile IL-18 during AP indicates that this cytokine was released early after AP onset and may play the key role in inflammatory and immune response. Positive correlation between serum IL-18 and commonly known early prognostic markers of AP severity suggest that serum IL-18 concentrations may represent another early marker indicating severe course of AP.

1 April 2004 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
UWUrszula Wereszczynska-Siemiatkowska
Urszula Wereszczynska-Siemiatkowska
Barbara MroczkoBarbara Mroczko
Barbara Mroczko
ASAndrzej Siemiatkowski
Andrzej Siemiatkowski
MSMaciej Szmitkowski
Maciej Szmitkowski
JMJustyna Moskwa
Justyna Moskwa
JKJuliusz Kosel
Juliusz Kosel

1 March 2003 in Pancreas
Verified
Journal Article
Closed access
UWU. Wereszczynska-Siemiatkowska
U. Wereszczynska-Siemiatkowska
ADAndrzej Dąbrowski
Andrzej Dąbrowski
ASA. Siemiatkowski
A. Siemiatkowski
Barbara MroczkoBarbara Mroczko
Barbara Mroczko
WLW. Laszewicz
W. Laszewicz
AGA. Gabryelewicz
A. Gabryelewicz
Excessive inflammatory response is one of the major causes of early mortality in acute pancreatitis (AP). To evaluate the serum profiles of E-selectin, interleukin (IL)–6, and IL-10 along with their correlation to the markers of oxidative stress and neutrophil activation in patients with AP and patients with nonpancreatic acute abdominal pain (NPAAP). This prospective clinical study included 56 patients with AP (28 with mild AP and 28 with severe AP) as well as 15 patients with NPAAP. Serum concentrations of E-selectin, IL-10, and IL-6 and plasma concentrations of polymorphonuclear leukocyte elastase (determined on days 1–3, 5, and 10 after admission) were the highest in severe AP during the first 3 days and then declined. At day 10, the E-selectin level in severe AP was still higher than that in mild AP, and the IL-10 concentration increased again. There was no elevation in the E-selectin concentration in NPAAP patients, and IL-10 levels remained unchanged in mild AP. Oxidative stress, measured by serum malondialdehyde and 4-hydroxyalkenals levels, was the most pronounced in severe AP. The serum E-selectin concentration is markedly elevated in severe AP and is less in mild AP but not in NPAAP. It may result from stimulation with different inflammatory mediators or indicate vascular endothelium injury mediated by oxidative stress, especially in the severe form of AP.